{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 2704, "items": [{"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:57:35Z", "timestamp": 1575107855987}, "publisher-location": "Chichester, UK", "reference-count": 59, "publisher": "John Wiley & Sons, Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/14651858.cd001257", "type": "reference-entry", "created": {"date-parts": [[2003, 11, 21]], "date-time": "2003-11-21T03:16:04Z", "timestamp": 1069384564000}, "source": "Crossref", "is-referenced-by-count": 5, "title": ["Polyunsaturated fatty acid supplementation for schizophrenia"], "prefix": "10.1002", "author": [{"given": "CB", "family": "Joy", "sequence": "first", "affiliation": []}, {"given": "R", "family": "Mumby-Croft", "sequence": "additional", "affiliation": []}, {"given": "LA", "family": "Joy", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2003, 4, 22]]}, "reference": [{"issue": "12", "key": "10.1002/14651858.CD001257-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "2071", "DOI": "10.1176/appi.ajp.158.12.2071", "article-title": "A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impariment in schizophrenia", "volume": "158", "author": "Fenton", "year": "2001", "journal-title": "American Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257-BIB5|cit2", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0920-9964(00)00083-9", "article-title": "Two double-blind placebo-controlled pilot stuides of eicosapentaenoic acid in the treatment of schizophrenia", "volume": "49", "author": "Peet", "year": "2001", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257-BIB2|cit3", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/S0920-9964(97)82601-1", "article-title": "Double-blind trial of N3 fatty acid supplementation in the treatment of schizophrenia", "volume": "24", "author": "Peet", "year": "1997", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257-BIB3|cit4", "author": "Peet", "volume": "29", "first-page": "160", "year": "1998", "journal-title": "Schizophrenia Research", "DOI": "10.1016/S0920-9964(97)88713-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD001257-BIB4|cit5", "author": "Shah", "volume": "29", "first-page": "158", "year": "1998", "journal-title": "Schizophrenia Research", "DOI": "10.1016/S0920-9964(97)88706-3", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD001257-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0920-9964(00)00083-9", "article-title": "Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia", "volume": "49", "author": "Peet", "year": "2001", "journal-title": "Schizophrenia Research"}, {"issue": "1", "key": "10.1002/14651858.CD001257-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/S0920-9964(00)90360-8", "article-title": "Double blind pilot study of eicosapentaenoic acid (EPA) as the sole treatment for schizophrenia", "volume": "41", "author": "Shah", "year": "2000", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257-BIB8|cit8", "author": "Horrobin", "article-title": "The role of phospholipids in schizophrenia", "series-title": "7th World Congress of Biological Psychiatry"}, {"key": "10.1002/14651858.CD001257-BIB12|cit9", "author": "Horrobin", "first-page": "232", "article-title": "Correlation between clinical improvement and red cell fatty acid changes when treating schizophrenia with eicospenetaenoic acid", "series-title": "Schizophrenia Research (8th International Congress on Schizophrenia Research)"}, {"issue": "1", "key": "10.1002/14651858.CD001257-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1054/plef.2001.0338", "article-title": "Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding", "volume": "66", "author": "Horrobin", "year": "2002", "journal-title": "Prostaglandins, Leukotrienes and Essential Fatty Acids"}, {"key": "10.1002/14651858.CD001257-BIB11|cit11", "author": "Peet", "first-page": "241", "article-title": "Eicosapentaenoic acid (EPA) is effective in relieving schizophrenic symptoms in patients on clozapine", "journal-title": "Schizophrenia Research (8th International Congress on Schizophrenia Research)"}, {"key": "10.1002/14651858.CD001257-BIB9|cit12", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/S0022-3956(01)00048-6", "article-title": "A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms", "volume": "36", "author": "Peet", "year": "2002", "journal-title": "Journal of Psychiatric Research"}, {"key": "10.1002/14651858.CD001257-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "912", "DOI": "10.1176/ajp.143.7.912", "article-title": "Essential fatty acid supplementation in tardive dyskinesia", "volume": "143", "author": "Wolkin", "year": "1986", "journal-title": "American Journal of Psychiatry"}, {"issue": "1/2", "key": "10.1002/14651858.CD001257-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0952-3278(96)90139-8", "article-title": "Membrane fatty acids, niacin flushing and clinical parameters", "volume": "55", "author": "Glen", "year": "1996", "journal-title": "Prostaglandins, Leukotrienes and Essential Fatty Acids"}, {"key": "10.1002/14651858.CD001257-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1192/bjp.169.5.610", "article-title": "Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia", "volume": "169", "author": "Heresco Levy", "year": "1996", "journal-title": "British Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257-BIB16|cit16", "first-page": "302", "article-title": "A trial of evening primrose oil in the treatment of chronic schizophrenia", "volume": "12", "author": "Holman", "year": "1983", "journal-title": "Journal of Orthomolecular Psychiatry"}, {"key": "10.1002/14651858.CD001257-BIB17|cit17", "author": "Maurer", "first-page": "S1", "year": "2002", "article-title": "Reduction of arachidonic acid levels by haloperidol in patients with schizophrenia", "series-title": "Schizophrenia Research (Abstracts of the 11th Biennial Winter Workshop on Schizophrenia)"}, {"issue": "supplement", "key": "10.1002/14651858.CD001257-BIB20|cit18", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1007/BF02637070", "article-title": "Fatty acids and schizophrenia", "volume": "31", "author": "Laugharne", "year": "1996", "journal-title": "Lipids"}, {"key": "10.1002/14651858.CD001257-BIB21|cit19", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1002/(SICI)1099-1077(199601)11:1<39::AID-HUP742>3.0.CO;2-#", "article-title": "Omega-3 fatty acid supplementation in schizophrenic patients", "volume": "11", "author": "Mellor", "year": "1996", "journal-title": "Human Psychopharmacology"}, {"key": "10.1002/14651858.CD001257-BIB19|cit20", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/0920-9964(95)00084-4", "article-title": "Schizophrenic symptoms and dietary intake of n-3 fatty acids", "volume": "18", "author": "Mellor", "year": "1995", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257-BIB18|cit21", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1016/S0952-3278(96)90148-9", "article-title": "Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation", "volume": "55", "author": "Peet", "year": "1996", "journal-title": "Prostaglandins, Luekotrienes and Essential Fatty Acids"}, {"issue": "1", "key": "10.1002/14651858.CD001257-BIB22|cit22", "first-page": "123", "article-title": "MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment", "volume": "13", "author": "Puri", "year": "2002", "journal-title": "Clinical Neuroscience"}, {"key": "10.1002/14651858.CD001257-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1016/0022-3956(73)90009-5", "article-title": "Corticosteroids in psychiatric patients: Subacute and diurnal effects on free fatty acid and catecholamine metabolism", "volume": "10", "author": "Silbergeld", "year": "1973", "journal-title": "Journal of Psychiatic Research"}, {"key": "10.1002/14651858.CD001257-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "362", "DOI": "10.1007/BF00180839", "article-title": "A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients", "volume": "88", "author": "Vaddadi", "year": "1986", "journal-title": "Psychopharmacology Berlin"}, {"key": "10.1002/14651858.CD001257-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1016/0165-1781(89)90146-7", "article-title": "A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia", "volume": "27", "author": "Vaddadi", "year": "1989", "journal-title": "Psychiatry Research"}, {"key": "10.1002/14651858.CD001257-BIB26|cit26", "author": "Vaddadi", "first-page": "333", "year": "1990", "article-title": "Essential Fatty Acids, Tardive Dyskinesia and Schizophrenia", "volume-title": "Omega-6 Essential Fatty acids: Pathophysiology and Roles in Clinical Medicine"}, {"key": "10.1002/14651858.CD001257-BIB27|cit27", "unstructured": "Elmsley R Oosthuizen PP Double-blind, randomized, parallel-group comparison of ethyl-eicosapentaenoic acid (ethyl-EP A) versus placebo as add-on medication in 84 patients with established tardive dyskinesia Stanley Foundation Research Programs (http://www.stanleyresearch.org) 2002"}, {"key": "10.1002/14651858.CD001257-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "1200", "DOI": "10.1136/bmj.313.7066.1200", "article-title": "Detecting skewness from summary information", "volume": "313", "author": "Altman", "year": "1996", "journal-title": "BMJ"}, {"key": "10.1002/14651858.CD001257-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1001/jama.276.8.637", "article-title": "Improving the quality of reporting of randomized controlled trials. The CONSORT statement [comment]", "volume": "276", "author": "Begg", "year": "1996", "journal-title": "JAMA"}, {"key": "10.1002/14651858.CD001257-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1136/bmj.315.7108.600", "article-title": "Statistics notes. Trials randomised in clusters", "volume": "315", "author": "Bland", "year": "1997", "journal-title": "BMJ"}, {"key": "10.1002/14651858.CD001257-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1111/j.1600-0447.1988.tb06388.x", "article-title": "Fat consumption and schizophrenia", "volume": "78", "author": "Christensen", "year": "1998", "journal-title": "Acta Psychiatrica Scandinavica"}, {"key": "10.1002/14651858.CD001257-BIB32|cit32", "author": "Clarke", "issue": "1", "year": "2000", "article-title": "Cochrane Collaboration Handbook", "journal-title": "The Cochrane Library [database on disk & CD ROM] The Cochrane Collaboration"}, {"key": "10.1002/14651858.CD001257-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1111/j.1471-4159.1992.tb08915.x", "article-title": "Participation of prostaglandin E2 in dopamine D2 receptor-dependent potentiation of arachidonic response", "volume": "59", "author": "Marzo", "year": "1992", "journal-title": "Journal of Neurochemisty"}, {"key": "10.1002/14651858.CD001257-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1007/BF02599201", "article-title": "The unit of analysis error in studies about physicians' patient care behavior", "volume": "7", "author": "Divine", "year": "1992", "journal-title": "Journal of General Internal Medicine"}, {"key": "10.1002/14651858.CD001257-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1136/bmj.315.7109.629", "article-title": "Bias in meta-analysis detected by a simple, graphical test", "volume": "315", "author": "Egger", "year": "1997", "journal-title": "BMJ"}, {"key": "10.1002/14651858.CD001257-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/0920-9964(94)90084-1", "article-title": "A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases", "volume": "12", "author": "Glen", "year": "1994", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "876", "DOI": "10.1093/oxfordjournals.aje.a009904", "article-title": "Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from Health Survey for England 1994", "volume": "149", "author": "Guilliford", "year": "1999", "journal-title": "American Journal of Epidemiology"}, {"key": "10.1002/14651858.CD001257-BIB38|cit38", "author": "Guy", "year": "1976", "volume-title": "ECDEU assessment manual for psychopharmacology. Publication ADM 76-338"}, {"key": "10.1002/14651858.CD001257-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/S0924-977X(97)00050-3", "article-title": "The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes", "volume": "8", "author": "Heresco-Levy", "year": "1998", "journal-title": "European Neuropsychopharmacology"}, {"key": "10.1002/14651858.CD001257-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "795", "DOI": "10.1016/0006-3223(91)90235-E", "article-title": "Fatty acid levels in the brains of schizophrenics and normal controls", "volume": "30", "author": "Horrobin", "year": "1991", "journal-title": "Biological Psychiatry"}, {"key": "10.1002/14651858.CD001257-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1016/0920-9964(94)90043-4", "article-title": "The membrane hypothesis of schizophrenia", "volume": "13", "author": "Horrobin", "year": "1994", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257-BIB42|cit42", "author": "Hunter", "issue": "1", "year": "2003", "article-title": "Risperidone versus typical antipsychotic medication for schizophrenia", "journal-title": "Cochrane Library"}, {"key": "10.1002/14651858.CD001257-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1017/S0264180100000904", "article-title": "Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study", "volume": "20", "author": "Jablensky", "year": "1992", "journal-title": "Psychological Medicine Monograph Supplement"}, {"key": "10.1002/14651858.CD001257-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0197-2456(95)00134-4", "article-title": "Assessing the quality of reports of randomized clinical trials: is blinding necessary?", "volume": "17", "author": "Jadad", "year": "1996", "journal-title": "Controlled Clinical Trials"}, {"key": "10.1002/14651858.CD001257-BIB45|cit45", "author": "Kay", "year": "1986", "volume-title": "Positive and negative syndrome scale (PANSS) manual"}, {"key": "10.1002/14651858.CD001257-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1192/bjp.176.3.249", "article-title": "Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia", "volume": "176", "author": "Marshall", "year": "2000", "journal-title": "British Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/0920-9964(95)00084-4", "article-title": "Schizophrenic symptoms and dietary intake of n-3 fatty acids", "volume": "18", "author": "Mellor", "year": "1995", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1002/(SICI)1099-1077(199601)11:1<39::AID-HUP742>3.0.CO;2-#", "article-title": "Omega-3 fatty acid supplementation in schizoprenic patients", "volume": "11", "author": "Mellor", "year": "1996", "journal-title": "Human Psychopharmacology"}, {"key": "10.1002/14651858.CD001257-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.1192/bjp.134.4.382", "article-title": "A new depression scale designed to be sensitive to change", "volume": "134", "author": "Montgomery", "year": "1979", "journal-title": "British Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257-BIB50|cit50", "author": "Mulrow", "article-title": "Cochrane Collaboration Handbook [updated 1 March 1997]", "journal-title": "The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration"}, {"key": "10.1002/14651858.CD001257-BIB51|cit51", "first-page": "53", "article-title": "Fatty acids and cell signalling", "volume": "12", "author": "Nunez EA", "year": "1993", "journal-title": "Prostaglandins Leukotrienes EFAs"}, {"key": "10.1002/14651858.CD001257-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/S0920-9964(97)82601-1", "article-title": "Fatty acid suplementation in schizophrenic patients", "volume": "24", "author": "Peet", "year": "1997", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "S189", "DOI": "10.1016/S0006-3223(97)87698-6", "article-title": "Normalisation of positive and negative symptoms of schizophrenia following dietary supplementation with essential fatty acids: a case study", "volume": "42", "author": "Puri", "year": "1997", "journal-title": "Biological Psychiatry"}, {"key": "10.1002/14651858.CD001257-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1001/jama.273.5.408", "article-title": "Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials", "volume": "273", "author": "Schulz", "year": "1995", "journal-title": "JAMA"}, {"key": "10.1002/14651858.CD001257-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1111/j.1600-0447.1970.tb02066.x", "article-title": "A rating scale for extra-pyramidal side-effects", "volume": "212", "author": "Simpson", "year": "1970", "journal-title": "Acta Psychiatrica Scandinavica Supplementum"}, {"key": "10.1002/14651858.CD001257-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "1181", "DOI": "10.1136/bmj.317.7167.1181", "article-title": "Content and quality of 2000 controlled trials in schizophrenia over 50 years", "volume": "317", "author": "Thornley", "year": "1998", "journal-title": "BMJ"}, {"key": "10.1002/14651858.CD001257-BIB57|cit57", "unstructured": "WHO Global Health Statistics Online Available: http//www.who.ch/msa/mnh/ems/rates/schizo.htm"}, {"key": "10.1002/14651858.CD001257-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1093/oxfordjournals.schbul.a033315", "article-title": "Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort", "volume": "24", "author": "Wiersma", "year": "1998", "journal-title": "Schizophrenia Bulletin"}, {"issue": "1", "key": "10.1002/14651858.CD001257-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/S0920-9964(00)90361-X", "article-title": "Polyunsaturated fatty acid supplementation (fish or evening primrose oil) for schizophrenia: a Cochrane review", "volume": "41", "author": "Joy", "year": "2000", "journal-title": "Schizophrenia Research"}], "container-title": ["Cochrane Database of Systematic Reviews"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/14651858.CD001257", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 2]], "date-time": "2018-08-02T14:58:41Z", "timestamp": 1533221921000}, "score": 48.280415, "editor": [{"given": "Claire", "family": "Joy", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2003, 4, 22]]}, "references-count": 59, "URL": "http://dx.doi.org/10.1002/14651858.cd001257", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T03:29:57Z", "timestamp": 1574220597961}, "update-to": [{"updated": {"date-parts": [[2006, 7, 19]], "date-time": "2006-07-19T00:00:00Z", "timestamp": 1153267200000}, "DOI": "10.1002/14651858.cd001257", "type": "new_version", "label": "New version"}], "reference-count": 82, "publisher": "Wiley", "content-domain": {"domain": ["wiley.com", "cochranelibrary.com"], "crossmark-restriction": true}, "DOI": "10.1002/14651858.cd001257.pub2", "type": "journal-article", "created": {"date-parts": [[2006, 7, 18]], "date-time": "2006-07-18T20:38:24Z", "timestamp": 1153255104000}, "update-policy": "http://dx.doi.org/10.1002/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Polyunsaturated fatty acid supplementation for schizophrenia"], "prefix": "10.1002", "author": [{"given": "Claire B", "family": "Irving", "sequence": "first", "affiliation": [{"name": "The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health, Sir Colin Campbell Building University of Nottingham Innovation Park, Triumph Road Nottingham UK NG7 2TU"}]}, {"given": "Roger", "family": "Mumby-Croft", "sequence": "additional", "affiliation": [{"name": "Westminster College; 62 Harpes Road Oxford UK OX2 7QL"}]}, {"given": "L A", "family": "Joy", "sequence": "additional", "affiliation": [{"name": "Puckmill Barn Frampton Mansell Gloucestershire UK GL5 6SX"}]}], "member": "311", "published-online": {"date-parts": [[2006, 7, 19]]}, "reference": [{"issue": "1", "key": "10.1002/14651858.CD001257.pub2-BIB0001|cit1", "first-page": "41", "article-title": "Ethyl-eicosapentaenoic acid (E-EPA) supplementation in early psychosis. A double-blind add on standard therapy in 80 drug naive or early treated first episode psychosis patients", "volume": "70", "author": "Berger", "year": "2004", "journal-title": "Schizophrenia Research"}, {"issue": "12", "key": "10.1002/14651858.CD001257.pub2-BIB0002|cit2", "doi-asserted-by": "crossref", "first-page": "1867", "DOI": "10.4088/JCP.v68n1206", "article-title": "Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomised placebo-controlled trial", "volume": "68", "author": "Berger", "year": "2007", "journal-title": "Journal of Clinical Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0003|cit3", "first-page": "475", "article-title": "Ethyl-Eicosapentaenoic acid (E-EPA) supplementation in early psychosis. A double-blind, randomised, placebo controlled trial (RCT) comparing 2g E-EPA versus placebo add on therapy in 80 drug naive or early treated first episode psychosis", "volume": "31", "author": "Berger", "year": "2005", "journal-title": "Schizophrenia Bulletin"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0004|cit4", "unstructured": "McConchie MA Berger GE Proffitt TM Yuen HP Wood S smith D Horrobin D McGorry PD Effect of diagnostic heterogeneity on response to ethyl-eicosapentaenoic acid (EPA) in first episode psychosis (FEP) Proceedings of the 12th Biennial Winter Workshop on Schizophrenia; 2004 Feb 7-13, Davos, Switzerland Davos 2004"}, {"issue": "1", "key": "10.1002/14651858.CD001257.pub2-BIB0005|cit5", "first-page": "40", "article-title": "Ethyl-Eicosapentaenoic acid (E-EPA) supplementation in first-episode psychosis: effects on cognition mediated by lipid metabolic status", "volume": "70", "author": "Proffitt", "year": "2004", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0006|cit6", "doi-asserted-by": "crossref", "first-page": "1596", "DOI": "10.1176/appi.ajp.159.9.1596", "article-title": "Randomised, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia", "volume": "159", "author": "Emsley", "year": "2002", "journal-title": "American Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0008|cit7", "unstructured": "Emsley R A double-blind, randomised, parallel-group comparison of ethyl-eicosapentaenoic acid (e-epa) versus placebo as add-on medication in patients with established tardive dyskinesia www.clinicaltrials.gov 2005"}, {"issue": "1", "key": "10.1002/14651858.CD001257.pub2-BIB0007|cit8", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1016/j.schres.2006.03.023", "article-title": "The effects of eicosapentaenoic acid in tardive dyskinesia: a randomised placebo-controlled trial", "volume": "84", "author": "Emsley", "year": "2006", "journal-title": "Schizophrenia Research"}, {"issue": "12", "key": "10.1002/14651858.CD001257.pub2-BIB0009|cit9", "doi-asserted-by": "crossref", "first-page": "2071", "DOI": "10.1176/appi.ajp.158.12.2071", "article-title": "A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia", "volume": "158", "author": "Fenton", "year": "2001", "journal-title": "American Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0010|cit10", "doi-asserted-by": "crossref", "first-page": "S159", "DOI": "10.1016/S0006-3223(00)00854-4", "article-title": "Randomised trial of supplemental EPA for residual symptoms of schizophrenia", "volume": "47", "author": "Fenton", "year": "2000", "journal-title": "Biological Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0011|cit11", "unstructured": "Fenton WS Dickerson F Boronow JJ Hibbein JR Knable MB Placebo-controlled trial of omega-3 fatty acid Proceedings of the 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia,USA Philadelphia 2002"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0015|cit12", "unstructured": "Peet M International multi-centre, double-blind, placebo controlled trial of EPA as an adjunct to existing neuroleptic treated schizophrenic patients National Research Register 2001"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0012|cit13", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0920-9964(00)00083-9", "article-title": "Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia", "volume": "49", "author": "Peet", "year": "2001", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0013|cit14", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/S0920-9964(97)82601-1", "article-title": "Double-blind trial of N3 fatty acid supplementation in the treatment of schizophrenia", "volume": "24", "author": "Peet", "year": "1997", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0014|cit15", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1016/S0920-9964(97)88713-0", "article-title": "Double-blind, placebo controlled trial of N-3 polyunsaturated fatty acids as an adjunct to neuroleptics", "volume": "29", "author": "Peet", "year": "1998", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0016|cit16", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1016/S0920-9964(97)88706-3", "article-title": "Eicosapentaenoic acid (EPA) as an adjunct in the treatment of schizophrenia", "volume": "29", "author": "Shah", "year": "1998", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0017|cit17", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0920-9964(00)00083-9", "article-title": "Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia", "volume": "49", "author": "Peet", "year": "2001", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0019|cit18", "unstructured": "Horrobin DF The role of phospholipids in schizophrenia Proceedings of the 7th World Congress of Biological Psychiatry; 2001 July 1-6; Berlin, Germany Berlin 2001", "DOI": "10.3109/15622970009150597", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0018|cit19", "unstructured": "Horrobin DF Bennett CN Peet M Correlation between clinical improvement and red cell fatty acid changes when treating schizophrenia with eicosapentaenoic acid Proceedings of the 8th International Congress on Schizophrenia Research; 2001 April 28- May 2; British Columbia, Canada British Columbia 2001 232"}, {"issue": "1", "key": "10.1002/14651858.CD001257.pub2-BIB0020|cit20", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1054/plef.2001.0338", "article-title": "Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding", "volume": "66", "author": "Horrobin", "year": "2002", "journal-title": "Prostaglandins, Leukotrienes and Essential Fatty Acids"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0022|cit21", "unstructured": "Peet M A multi-centre, double-blind, randomised, parallel group, placebo controlled, dose ranging pilot study of ethyl eicosapentaenoate (ethly EPA) in patients with schizophrenia National Research Register 2001"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0023|cit22", "unstructured": "Peet M Eicosapentaenoic acid (EPA) is effective in relieving schizophrenic symptoms in patients on clozapine Proceedings of the 8th International Congress on Schizophrenia Research; 2001 April 28 - May 2; British Columbia, Canada British Columbia 2001 241 2"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0021|cit23", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/S0022-3956(01)00048-6", "article-title": "A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms", "volume": "36", "author": "Peet", "year": "2002", "journal-title": "Journal of Psychiatric Research"}, {"issue": "1", "key": "10.1002/14651858.CD001257.pub2-BIB0024|cit24", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/S0920-9964(00)90360-8", "article-title": "Double blind pilot study of eicosapentaenoic acid (EPA) as the sole treatment for schizophrenia", "volume": "41", "author": "Shah", "year": "2000", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0025|cit25", "doi-asserted-by": "crossref", "first-page": "912", "DOI": "10.1176/ajp.143.7.912", "article-title": "Essential fatty acid supplementation in tardive dyskinesia", "volume": "143", "author": "Wolkin", "year": "1986", "journal-title": "American Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0028|cit26", "unstructured": "Amminger GP Indicated prevention with omega-3 fatty acids in adolescents with 'at-risk-mental-state' for psychosis: a randomised, double blind, placebo-controlled treatment trial www.clinicaltrials.gov 2006", "DOI": "10.1016/S0920-9964(06)70292-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0026|cit27", "unstructured": "Amminger GP Schafer MR Is it feasible to conduct a RCT in ultra-high risk individuals at a child and adolescent psychiatric service? Proceedings of the 5th International Conference on Early Psychosis; 2006 Oct 4-6; Birmingham, UK Birmingham 2006"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0027|cit28", "unstructured": "Amminger GP Schafer MR Indicated prevention with omega-3 fatty acids in adolescents at ultra-high risk for psychosis - rationale, methods and 3-months outcome Proceedings of the 5th International Conference on Early Psychosis; 2006 Oct 4-6, Birmingham, UK Birmingham 2006", "DOI": "10.1016/S0920-9964(06)70292-4", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "10.1002/14651858.CD001257.pub2-BIB0029|cit29", "first-page": "418", "article-title": "Omega-3 fatty acids reduce the risk of early transition to psychosis in ultra-high risk individuals: a double-blind randomised, placebo-controlled treatment study", "volume": "33", "author": "AmmingerG", "year": "2007", "journal-title": "Schizophrenia Bulletin"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0030|cit30", "unstructured": "Klier C Hollmann M Schlogelhofer M Mossaheb N Friedrich M Amminger PG Indicated prevention with omega-3 fatty acids (epa/dha) in adolescents with \"at-risk-mental-state\" for psychosis Proceedings of the XIII World Congress of Psychiatry; 2005 Sept 10-15; Cairo, Egypt Cairo 2005"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0031|cit31", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0952-3278(96)90139-8", "article-title": "Membrane fatty acids, niacin flushing and clinical parameters", "volume": "55", "author": "Glen", "year": "1996", "journal-title": "Prostaglandins, Leukotrienes and Essential Fatty Acids"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0032|cit32", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1192/bjp.169.5.610", "article-title": "Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia", "volume": "169", "author": "Heresco Levy", "year": "1996", "journal-title": "British Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0033|cit33", "first-page": "302", "article-title": "A trial of evening primrose oil in the treatment of chronic schizophrenia", "volume": "12", "author": "Holman", "year": "1983", "journal-title": "Journal of Orthomolecular Psychiatry"}, {"issue": "3 suppl 1", "key": "10.1002/14651858.CD001257.pub2-BIB0034|cit34", "first-page": "209", "article-title": "Reduction of arachidonic acid levels by haloperidol in patients with schizophrenia", "volume": "53", "author": "Maurer", "year": "2002", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0035|cit35", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1007/BF02637070", "article-title": "Fatty acids and schizophrenia", "volume": "31", "author": "Laugharne", "year": "1996", "journal-title": "Lipids"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0036|cit36", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1002/(SICI)1099-1077(199601)11:1<39::AID-HUP742>3.0.CO;2-#", "article-title": "Omega-3 fatty acid supplementation in schizophrenic patients", "volume": "11", "author": "Mellor", "year": "1996", "journal-title": "Human Psychopharmacology"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0037|cit37", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/0920-9964(95)00084-4", "article-title": "Schizophrenic symptoms and dietary intake of n-3 fatty acids", "volume": "18", "author": "Mellor", "year": "1995", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0038|cit38", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1016/S0952-3278(96)90148-9", "article-title": "Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation", "volume": "55", "author": "Peet", "year": "1996", "journal-title": "Prostaglandins, Leukotrienes and Essential Fatty Acids"}, {"issue": "1", "key": "10.1002/14651858.CD001257.pub2-BIB0039|cit39", "first-page": "123", "article-title": "MRI and neuropsychological improvement in huntington disease following ethyl-EPA treatment", "volume": "13", "author": "Puri", "year": "2002", "journal-title": "Clinical Neuroscience"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0040|cit40", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1016/0022-3956(73)90009-5", "article-title": "Corticosteroids in psychiatric patients: Subacute and diurnal effects on free fatty acid and catecholamine metabolism", "volume": "10", "author": "Silbergeld", "year": "1973", "journal-title": "Journal of Psychiatric Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0041|cit41", "doi-asserted-by": "crossref", "first-page": "362", "DOI": "10.1007/BF00180839", "article-title": "A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients", "volume": "88", "author": "Vaddadi", "year": "1986", "journal-title": "Psychopharmacology Berlin"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0042|cit42", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1016/0165-1781(89)90146-7", "article-title": "A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia", "volume": "27", "author": "Vaddadi", "year": "1989", "journal-title": "Psychiatry Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0043|cit43", "author": "Vaddadi", "first-page": "333", "year": "1990", "article-title": "Essential fatty acids, tardive dyskinesia and schizophrenia", "volume-title": "Omega-6 Essential Fatty acids: Pathophysiology and Roles in Clinical Medicine"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0044|cit44", "unstructured": "Bentsen H Lingjaerde O A multicentre, placebo-controlled trial of eicosapentaenoic acid (EPA) and antioxidant supplementation in the treatment of schizophrenia and related disorders www.clinicaltrials.gov 2007"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0045|cit45", "first-page": "529", "article-title": "The effects of a fatty acid and antioxidants on neuropsychological functioning in schizophrenia and related psychoses", "volume": "33", "author": "Landro", "year": "2007", "journal-title": "Schizophrenia Bulletin"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0046|cit46", "unstructured": "Blanchet PJ Stip E Efficacy of docosahexaenoic acid on tardive dyskinesia www.clinicaltrials.gov 2008"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0047|cit47", "unstructured": "Korbanic CJ Yao JK CAD risk in schizophrenia: effect of omega-3 fatty acid supplementation www.clinicaltrials.gov 2005"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0048|cit48", "unstructured": "Murck H A multicentre, double blind, randomised, parallel group, placebo controlled dose ranging pilot study of ethyl-eicosapentaenoate (ethyl-epa) in patients with schizophrenia Current Controlled Trials 2001"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0049|cit49", "unstructured": "Richtand N Omega-3 fatty acid deficiency replacement in early schizophrenia www.clinicaltrials.gov 2007"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0050|cit50", "doi-asserted-by": "crossref", "first-page": "1200", "DOI": "10.1136/bmj.313.7066.1200", "article-title": "Detecting skewness from summary information", "volume": "313", "author": "Altman", "year": "1996", "journal-title": "BMJ"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0051|cit51", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1001/jama.1996.03540080059030", "article-title": "Improving the quality of reporting of randomised controlled trials. The CONSORT statement [comment]", "volume": "276", "author": "Begg", "year": "1996", "journal-title": "JAMA"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0052|cit52", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1136/bmj.315.7108.600", "article-title": "Statistics notes. Trials randomised in clusters", "volume": "315", "author": "Bland", "year": "1997", "journal-title": "BMJ"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0053|cit53", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1111/j.1600-0447.1988.tb06388.x", "article-title": "Fat consumption and schizophrenia", "volume": "78", "author": "Christensen", "year": "1998", "journal-title": "Acta Psychiatrica Scandinavica"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0054|cit54", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1111/j.1471-4159.1992.tb08915.x", "article-title": "Participation of prostaglandin E2 in dopamine D2 receptor-dependent potentiation of arachidonic response", "volume": "59", "author": "Marzo", "year": "1992", "journal-title": "Journal of Neurochemisty"}, {"issue": "6", "key": "10.1002/14651858.CD001257.pub2-BIB0055|cit55", "first-page": "623", "article-title": "The unit of analysis error in studies about physicians' patient care behaviour", "volume": "7", "author": "Divine", "year": "1992", "journal-title": "Journal of Internal Medicine"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0056|cit56", "doi-asserted-by": "crossref", "first-page": "2971", "DOI": "10.1002/sim.1301", "article-title": "Issues in the meta-analysis of cluster randomised trials", "volume": "21", "author": "Donner", "year": "2002", "journal-title": "Statistics in Medicine"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0057|cit57", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1136/bmj.315.7109.629", "article-title": "Bias in meta-analysis, detected by a simple graphical test", "volume": "315", "author": "Egger", "year": "1997", "journal-title": "BMJ"}, {"issue": "1", "key": "10.1002/14651858.CD001257.pub2-BIB0058|cit58", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.1093/ije/31.1.140", "article-title": "Meta-analyses involving cross-over trials: methodological issues", "volume": "31", "author": "Elbourne", "year": "2002", "journal-title": "International Journal of Epidemiology"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0059|cit59", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/0920-9964(94)90084-1", "article-title": "A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases", "volume": "12", "author": "Glen", "year": "1994", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0060|cit60", "doi-asserted-by": "crossref", "first-page": "876", "DOI": "10.1093/oxfordjournals.aje.a009904", "article-title": "Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from Health Survey for England 1994", "volume": "149", "author": "Gulliford", "year": "1999", "journal-title": "American Journal of Epidemiology"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0061|cit61", "author": "Guy", "year": "1976", "volume-title": "ECDEU assessment manual for psychopharmacology"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0062|cit62", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/S0924-977X(97)00050-3", "article-title": "The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes", "volume": "8", "author": "Heresco-Levy", "year": "1998", "journal-title": "European Neuropsychopharmacology"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0063|cit63", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1136/bmj.327.7414.557", "article-title": "Measuring inconsistency in meta-analyses", "volume": "327", "author": "Higgins", "year": "2003", "journal-title": "BMJ"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0064|cit64", "author": "Higgins", "year": "2008", "volume-title": "Cochrane Handbook for systematic reviews of interventions 5.0.1 [updated September 2008]", "DOI": "10.1002/9780470712184", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0065|cit65", "doi-asserted-by": "crossref", "first-page": "795", "DOI": "10.1016/0006-3223(91)90235-E", "article-title": "Fatty acid levels in the brains of schizophrenics and normal controls", "volume": "30", "author": "Horrobin", "year": "1991", "journal-title": "Biological Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0066|cit66", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1016/0920-9964(94)90043-4", "article-title": "The membrane hypothesis of schizophrenia", "volume": "13", "author": "Horrobin", "year": "1994", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0067|cit67", "author": "Hunter", "issue": "1", "year": "2003", "article-title": "Risperidone versus typical antipsychotic medication for schizophrenia", "journal-title": "Cochrane Database of Systematic Reviews", "DOI": "10.1002/14651858.CD000440", "doi-asserted-by": "publisher"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0068|cit68", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1017/S0264180100000904", "article-title": "Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study", "volume": "20", "author": "Jablensky", "year": "1992", "journal-title": "Psychological Medicine Monograph Supplement"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0069|cit69", "author": "Kay", "year": "1986", "volume-title": "Positive and Negative Syndrome Scale(PANSS) manual"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0070|cit70", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1192/bjp.176.3.249", "article-title": "Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia", "volume": "176", "author": "Marshall", "year": "2000", "journal-title": "British Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0071|cit71", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/0920-9964(95)00084-4", "article-title": "Schizophrenic symptoms and dietary intake of n-3 fatty acids", "volume": "18", "author": "Mellor", "year": "1995", "journal-title": "Schizophrenia Research"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0072|cit72", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1002/(SICI)1099-1077(199601)11:1<39::AID-HUP742>3.0.CO;2-#", "article-title": "Omega-3 fatty acid supplementation in schizophrenic patients", "volume": "11", "author": "Mellor", "year": "1996", "journal-title": "Human Psychopharmacology"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0073|cit73", "doi-asserted-by": "crossref", "first-page": "1987", "DOI": "10.1001/jama.285.15.1987", "article-title": "The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials", "volume": "285", "author": "Moher", "year": "2001", "journal-title": "JAMA"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0074|cit74", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.1192/bjp.134.4.382", "article-title": "A new depression scale designed to be sensitive to change", "volume": "134", "author": "Montgomery", "year": "1979", "journal-title": "British Journal of Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0075|cit75", "first-page": "53", "article-title": "Fatty acids and cell signalling", "volume": "12", "author": "Nunez", "year": "1993", "journal-title": "Prostaglandins Leukotrienes EFAs"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0076|cit76", "doi-asserted-by": "crossref", "first-page": "S189", "DOI": "10.1016/S0006-3223(97)87698-6", "article-title": "Normalisation of positive and negative symptoms of schizophrenia following dietary supplementation with essential fatty acids: a case study", "volume": "42", "author": "Puri", "year": "1997", "journal-title": "Biological Psychiatry"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0077|cit77", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1111/j.1600-0447.1970.tb02066.x", "article-title": "A rating scale for extra-pyramidal side-effects", "volume": "212", "author": "Simpson", "year": "1970", "journal-title": "Acta Psychiatrica Scandinavica Supplementum"}, {"issue": "5", "key": "10.1002/14651858.CD001257.pub2-BIB0078|cit78", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.3310/hta3050", "article-title": "Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review", "volume": "3", "author": "Ukoumunne", "year": "1999", "journal-title": "Health Technology Assessment"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0079|cit79", "unstructured": "WHO Global Health Statistics Online Available: http//www.who.ch/msa/mnh/ems/rates/schizo.htm."}, {"key": "10.1002/14651858.CD001257.pub2-BIB0080|cit80", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1093/oxfordjournals.schbul.a033315", "article-title": "Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort", "volume": "24", "author": "Wiersma", "year": "1998", "journal-title": "Schizophrenia Bulletin"}, {"key": "10.1002/14651858.CD001257.pub2-BIB0081|cit81", "unstructured": "Xia J Adams CE Bhagat N Bhagat V Bhoopathi P El-Sayeh H Pinfold V Takriti Y The Leeds Outcomes Stakeholders Survey (LOSS) Study Proceedings of the 15th Cochrane Colloquium; 2007 Oct 23-27; Sao Paulo 2007"}, {"issue": "1", "key": "10.1002/14651858.CD001257.pub2-BIB0082|cit82", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/S0920-9964(00)90361-X", "article-title": "Polyunsaturated fatty acid supplementation (fish or evening primrose oil) for schizophrenia: a Cochrane review", "volume": "41", "author": "Joy", "year": "2000", "journal-title": "Schizophrenia Research"}], "container-title": ["Cochrane Database of Systematic Reviews"], "language": "en", "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/14651858.CD001257.pub2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 20]], "date-time": "2019-04-20T03:51:40Z", "timestamp": 1555732300000}, "score": 46.747, "editor": [{"name": "Cochrane Schizophrenia Group", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2006, 7, 19]]}, "references-count": 82, "URL": "http://dx.doi.org/10.1002/14651858.cd001257.pub2", "relation": {"cites": []}, "ISSN": ["1465-1858"], "issn-type": [{"value": "1465-1858", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T21:47:08Z", "timestamp": 1574718428096}, "reference-count": 0, "publisher": "Portland Press Ltd.", "issue": "3", "content-domain": {"domain": ["portlandpress.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1967, 9, 1]]}, "DOI": "10.1042/bj1041026", "type": "journal-article", "created": {"date-parts": [[2015, 8, 10]], "date-time": "2015-08-10T19:11:36Z", "timestamp": 1439233896000}, "page": "1026-1032", "update-policy": "http://dx.doi.org/10.1042/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 57, "title": ["Turnover of mitochondrial components of normal and essential fatty acid-deficient rats"], "prefix": "10.1042", "volume": "104", "author": [{"given": "E", "family": "Bailey", "sequence": "first", "affiliation": []}, {"given": "CB", "family": "Taylor", "sequence": "additional", "affiliation": []}, {"given": "W", "family": "Bartley", "sequence": "additional", "affiliation": []}], "member": "288", "container-title": ["Biochemical Journal"], "language": "en", "link": [{"URL": "http://portlandpress.com/biochemj/article-pdf/104/3/1026/759244/bj1041026.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://portlandpress.com/biochemj/article-pdf/104/3/1026/759244/bj1041026.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 25]], "date-time": "2019-10-25T00:33:50Z", "timestamp": 1571963630000}, "score": 23.27737, "issued": {"date-parts": [[1967, 9, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1967, 9, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1042/bj1041026", "ISSN": ["0006-2936"], "issn-type": [{"value": "0006-2936", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T18:47:26Z", "timestamp": 1576781246402}, "reference-count": 20, "publisher": "IOS Press", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JAD"], "published-print": {"date-parts": [[2015, 10, 1]]}, "DOI": "10.3233/jad-150102", "type": "journal-article", "created": {"date-parts": [[2015, 10, 6]], "date-time": "2015-10-06T16:07:59Z", "timestamp": 1444147679000}, "page": "805-812", "source": "Crossref", "is-referenced-by-count": 31, "title": ["Plasma Fatty Acid Profiles in Relation to\u00a0Cognition and Gender in Alzheimer\u2019s Disease Patients During Oral Omega-3 Fatty\u00a0Acid Supplementation: The OmegAD\u00a0Study"], "prefix": "10.3233", "volume": "48", "author": [{"given": "Maria", "family": "Eriksdotter", "sequence": "first", "affiliation": [{"name": "Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Stockholm"}, {"name": "Department of Geriatric Medicine, Karolinska University Hospital, Huddinge, Stockholm"}]}, {"given": "Inger", "family": "Vedin", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Division of Hematology, Karolinska Institutet, Huddinge, Stockholm"}]}, {"given": "Farshad", "family": "Falahati", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Stockholm"}]}, {"given": "Yvonne", "family": "Freund-Levi", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Stockholm"}]}, {"given": "Erik", "family": "Hjorth", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Care Sciences and Society (NVS), Division of Neurodegeneration, Karolinska Institutet, Huddinge, Stockholm"}]}, {"given": "Gerd", "family": "Faxen-Irving", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Stockholm"}]}, {"given": "Lars-Olof", "family": "Wahlund", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Stockholm"}, {"name": "Department of Geriatric Medicine, Karolinska University Hospital, Huddinge, Stockholm"}]}, {"given": "Marianne", "family": "Schultzberg", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Care Sciences and Society (NVS), Division of Neurodegeneration, Karolinska Institutet, Huddinge, Stockholm"}]}, {"given": "Hans", "family": "Basun", "sequence": "additional", "affiliation": [{"name": "Division of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden"}, {"name": "Department of Geriatric Medicine, Akademiska sjukhuset, Uppsala, Sweden"}]}, {"given": "Tommy", "family": "Cederholm", "sequence": "additional", "affiliation": [{"name": "Division of Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden"}, {"name": "Department of Geriatric Medicine, Akademiska sjukhuset, Uppsala, Sweden"}]}, {"given": "Jan", "family": "Palmblad", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Division of Hematology, Karolinska Institutet, Huddinge, Stockholm"}]}], "member": "7437", "reference": [{"key": "10.3233/JAD-150102_ref1", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1038/nature13479", "article-title": "Pro-resolving lipid mediators are leads for resolution physiology", "volume": "510", "author": "Serhan", "year": "2014", "journal-title": "Nature"}, {"key": "10.3233/JAD-150102_ref2", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1097/MOL.0000000000000041", "article-title": "Update on cardiometabolic health effects of \u03c9-3 fatty acids", "volume": "25", "author": "Kromhout", "year": "2014", "journal-title": "Curr Opin Lipidol"}, {"key": "10.3233/JAD-150102_ref3", "doi-asserted-by": "crossref", "first-page": "1482.e1417", "DOI": "10.1016/j.neurobiolaging.2011.12.014", "article-title": "Effects of \u03c9-3 fatty acids on cognitive performance: A meta-analysis", "volume": "33", "author": "Mazereeuw", "year": "2012", "journal-title": "Neurobiol Aging"}, {"key": "10.3233/JAD-150102_ref4", "doi-asserted-by": "crossref", "first-page": "672", "DOI": "10.3945/an.113.004556", "article-title": "\u03c9-3 fatty acids in the prevention of cognitive decline in humans", "volume": "4", "author": "Cederholm", "year": "2013", "journal-title": "Adv Nutr"}, {"key": "10.3233/JAD-150102_ref5", "doi-asserted-by": "crossref", "first-page": "1402", "DOI": "10.1001/archneur.63.10.1402", "article-title": "Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial", "volume": "63", "author": "Freund-Levi", "year": "2006", "journal-title": "Arch Neurol"}, {"key": "10.3233/JAD-150102_ref6", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1212/01.wnl.0000316808.21277.69", "article-title": "Detecting Alzheimer disease before it happens: The key to prevention?", "volume": "71", "author": "Quinn", "year": "2008", "journal-title": "Neurology"}, {"key": "10.3233/JAD-150102_ref7", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1017/S0029665108005983", "article-title": "Gender differences in the n-3 fatty acid content of tissues", "volume": "67", "author": "Childs", "year": "2008", "journal-title": "Proc Nutr Soc"}, {"key": "10.3233/JAD-150102_ref8", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1159/000345599", "article-title": "Gender differences in the long-chain polyunsaturated fatty acid status: Systematic review of 51 publications", "volume": "62", "author": "Lohner", "year": "2013", "journal-title": "Ann Nutr Metab"}, {"key": "10.3233/JAD-150102_ref9", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1017/S0007114513002985", "article-title": "Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans", "volume": "111", "author": "Walker", "year": "2014", "journal-title": "Br J Nutr"}, {"key": "10.3233/JAD-150102_ref10", "doi-asserted-by": "crossref", "first-page": "618", "DOI": "10.1093/ajcn/88.3.618", "article-title": "Effect of sex and genotype on cardiovascular biomarker response to fish oils: The FINGEN Study", "volume": "88", "author": "Caslake", "year": "2008", "journal-title": "Am J Clin Nutr"}, {"key": "10.3233/JAD-150102_ref11", "doi-asserted-by": "crossref", "first-page": "e000513", "DOI": "10.1161/JAHA.113.000513", "article-title": "Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: A dose-response randomized controlled trial", "volume": "2", "author": "Flock", "year": "2013", "journal-title": "J Am Heart Assoc"}, {"key": "10.3233/JAD-150102_ref12", "doi-asserted-by": "crossref", "first-page": "1956", "DOI": "10.3390/nu6051956", "article-title": "Randomized controlled trial examining the effects of fish oil and multivitamin supplementation on the incorporation of n-3 and n-6 fatty acids into red blood cells", "volume": "6", "author": "Pipingas", "year": "2014", "journal-title": "Nutrients"}, {"key": "10.3233/JAD-150102_ref13", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1111/j.1532-5415.2008.02055.x", "article-title": "Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer\u2019s disease: The omega-3 Alzheimer\u2019s disease study", "volume": "57", "author": "Irving", "year": "2009", "journal-title": "J Am Geriatr Soc"}, {"key": "10.3233/JAD-150102_ref14", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1016/0022-3956(75)90026-6", "article-title": "\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician", "volume": "12", "author": "Folstein", "year": "1975", "journal-title": "J Psychiatr Res"}, {"issue": "Suppl 2", "key": "10.3233/JAD-150102_ref15", "doi-asserted-by": "crossref", "first-page": "S13", "DOI": "10.1097/00002093-199700112-00003", "article-title": "Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer\u2019s Disease Assessment Scale that broaden its scope. The Alzheimer\u2019s Disease Cooperative Study", "volume": "11", "author": "Mohs", "year": "1997", "journal-title": "Alzheimer Dis Assoc Disord"}, {"key": "10.3233/JAD-150102_ref16", "doi-asserted-by": "crossref", "first-page": "428", "DOI": "10.1111/joim.12166", "article-title": "Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer\u2019s disease: The OmegAD study", "volume": "275", "author": "Freund Levi", "year": "2014", "journal-title": "J Intern Med"}, {"key": "10.3233/JAD-150102_ref17", "doi-asserted-by": "crossref", "first-page": "1545", "DOI": "10.1001/archneur.63.11.1545", "article-title": "Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study", "volume": "63", "author": "Schaefer", "year": "2006", "journal-title": "Arch Neurol"}, {"key": "10.3233/JAD-150102_ref18", "first-page": "311", "article-title": "Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids", "volume": "144", "author": "Danthiir", "year": "2014", "journal-title": "J\u00a0Nutr"}, {"key": "10.3233/JAD-150102_ref19", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.3233/JAD-2003-5407", "article-title": "Omega-3 fatty acids and risk of cognitive impairment and dementia", "volume": "5", "author": "Laurin", "year": "2003", "journal-title": "J Alzheimers Dis"}, {"key": "10.3233/JAD-150102_ref20", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1007/s12170-014-0407-4", "article-title": "Omega-3 Fatty Acid Blood Levels Clinical Significance Update", "volume": "8", "author": "Superko", "year": "2014", "journal-title": "Curr Cardiovasc Risk Rep"}], "container-title": ["Journal of Alzheimer's Disease"], "link": [{"URL": "https://content.iospress.com/download?id=10.3233/JAD-150102", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T09:49:52Z", "timestamp": 1575366592000}, "score": 21.66238, "issued": {"date-parts": [[2015, 10, 1]]}, "references-count": 20, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.3233/jad-150102", "relation": {"cites": []}, "ISSN": ["1387-2877", "1875-8908"], "issn-type": [{"value": "1387-2877", "type": "print"}, {"value": "1875-8908", "type": "electronic"}], "subject": ["Clinical Psychology", "Geriatrics and Gerontology", "Psychiatry and Mental health", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:29:00Z", "timestamp": 1574105340550}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "10", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 10, 1]], "date-time": "1996-10-01T00:00:00Z", "timestamp": 844128000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Nutrition Research"], "published-print": {"date-parts": [[1996, 10]]}, "DOI": "10.1016/0271-5317(96)00195-9", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T23:13:32Z", "timestamp": 1027638812000}, "page": "1761-1765", "source": "Crossref", "is-referenced-by-count": 8, "title": ["The effect of dietary fat type on the fatty acid composition of sphingomyelin in rat liver and heart"], "prefix": "10.1016", "volume": "16", "author": [{"given": "WJ", "family": "Bettger", "sequence": "first", "affiliation": []}, {"given": "CB", "family": "Blackadar", "sequence": "additional", "affiliation": []}, {"given": "ML", "family": "McCorquodale", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Nutrition Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0271531796001959?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0271531796001959?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T08:56:42Z", "timestamp": 1555577802000}, "score": 21.534544, "issued": {"date-parts": [[1996, 10]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[1996, 10]]}, "issue": "10"}, "alternative-id": ["0271531796001959"], "URL": "http://dx.doi.org/10.1016/0271-5317(96)00195-9", "ISSN": ["0271-5317"], "issn-type": [{"value": "0271-5317", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T11:33:39Z", "timestamp": 1574249619042}, "reference-count": 0, "publisher": "Portico", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1990, 6]]}, "DOI": "10.1037/028756", "type": "journal-article", "created": {"date-parts": [[2006, 12, 13]], "date-time": "2006-12-13T07:37:54Z", "timestamp": 1165995474000}, "page": "619-620", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Review of Schizophrenia: Scientific\n                                                  Progress."], "prefix": "10.3730", "volume": "35", "author": [{"given": "Irving I.", "family": "Gottesman", "sequence": "first", "affiliation": []}], "member": "1320", "container-title": ["Contemporary Psychology: A Journal of Reviews"], "deposited": {"date-parts": [[2018, 4, 19]], "date-time": "2018-04-19T21:06:46Z", "timestamp": 1524172006000}, "score": 20.585537, "issued": {"date-parts": [[1990, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 6]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1037/028756", "ISSN": ["0010-7549"], "issn-type": [{"value": "0010-7549", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T18:02:57Z", "timestamp": 1575136977649}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Am. Chem. Soc."], "published-print": {"date-parts": [[1938, 3]]}, "DOI": "10.1021/ja01270a032", "type": "journal-article", "created": {"date-parts": [[2005, 3, 19]], "date-time": "2005-03-19T16:26:36Z", "timestamp": 1111249596000}, "page": "612-614", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Isolation and Properties of Gorlic Acid, an Optically Active Liquid Fatty Acid"], "prefix": "10.1021", "volume": "60", "author": [{"given": "Howard Irving", "family": "Cole", "sequence": "first", "affiliation": []}, {"given": "Humberto T.", "family": "Cardoso", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Journal of the American Chemical Society"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/ja01270a032", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 9]], "date-time": "2019-10-09T03:21:07Z", "timestamp": 1570591267000}, "score": 20.440845, "issued": {"date-parts": [[1938, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1938, 3]]}, "issue": "3"}, "alternative-id": ["10.1021/ja01270a032"], "URL": "http://dx.doi.org/10.1021/ja01270a032", "ISSN": ["0002-7863", "1520-5126"], "issn-type": [{"value": "0002-7863", "type": "print"}, {"value": "1520-5126", "type": "electronic"}], "subject": ["Colloid and Surface Chemistry", "Biochemistry", "General Chemistry", "Catalysis"]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T05:38:24Z", "timestamp": 1574573904556}, "reference-count": 0, "publisher": "Project Muse", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Perspectives in Biology and Medicine"], "published-print": {"date-parts": [[1967]]}, "DOI": "10.1353/pbm.1967.0019", "type": "journal-article", "created": {"date-parts": [[2015, 1, 11]], "date-time": "2015-01-11T14:15:17Z", "timestamp": 1420985717000}, "page": "643-678", "source": "Crossref", "is-referenced-by-count": 44, "title": ["An Hypothesis Concerning the Role of Carnitine in the Control of Interrelations between Fatty Acid and Carbohydrate Metabolism"], "prefix": "10.1353", "volume": "10", "author": [{"given": "Irving B.", "family": "Fritz", "sequence": "first", "affiliation": []}], "member": "147", "container-title": ["Perspectives in Biology and Medicine"], "language": "en", "deposited": {"date-parts": [[2015, 1, 11]], "date-time": "2015-01-11T14:15:25Z", "timestamp": 1420985725000}, "score": 20.254938, "issued": {"date-parts": [[1967]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1967]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1353/pbm.1967.0019", "ISSN": ["1529-8795"], "issn-type": [{"value": "1529-8795", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T20:37:04Z", "timestamp": 1574714224072}, "reference-count": 0, "publisher": "International Society for Horticultural Science (ISHS)", "issue": "269", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Acta Hortic."], "published-print": {"date-parts": [[1990, 8]]}, "DOI": "10.17660/actahortic.1990.269.19", "type": "journal-article", "created": {"date-parts": [[2015, 7, 27]], "date-time": "2015-07-27T13:27:01Z", "timestamp": 1438003621000}, "page": "141-152", "source": "Crossref", "is-referenced-by-count": 7, "title": ["CHANGE IN THE FATTY ACID COMPOSITION OF AVOCADO FRUIT DURING ONTOGENY, COLD STORAGE AND RIPENING"], "prefix": "10.17660", "author": [{"given": "Irving L.", "family": "Eaks", "sequence": "first", "affiliation": []}], "member": "7038", "container-title": ["Acta Horticulturae"], "link": [{"URL": "http://www.actahort.org/members/showpdf?booknrarnr=269_19", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 5]], "date-time": "2018-01-05T14:01:47Z", "timestamp": 1515160907000}, "score": 20.254938, "issued": {"date-parts": [[1990, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 8]]}, "issue": "269"}, "URL": "http://dx.doi.org/10.17660/actahortic.1990.269.19", "ISSN": ["0567-7572", "2406-6168"], "issn-type": [{"value": "0567-7572", "type": "print"}, {"value": "2406-6168", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T15:42:23Z", "timestamp": 1575214943359}, "reference-count": 0, "publisher": "American Physiological Society", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Physiological Reviews"], "published-print": {"date-parts": [[1961, 1, 1]]}, "DOI": "10.1152/physrev.1961.41.1.52", "type": "journal-article", "created": {"date-parts": [[2017, 12, 24]], "date-time": "2017-12-24T17:42:19Z", "timestamp": 1514137339000}, "page": "52-129", "source": "Crossref", "is-referenced-by-count": 336, "title": ["Factors Influencing the Rates of Long-Chain Fatty Acid Oxidation and Synthesis in Mammalian Systems"], "prefix": "10.1152", "volume": "41", "author": [{"given": "Irving B.", "family": "Fritz", "sequence": "first", "affiliation": []}], "member": "24", "container-title": ["Physiological Reviews"], "language": "en", "link": [{"URL": "https://www.physiology.org/doi/pdf/10.1152/physrev.1961.41.1.52", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 9]], "date-time": "2019-09-09T01:50:12Z", "timestamp": 1567993812000}, "score": 20.254938, "issued": {"date-parts": [[1961, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1961, 1, 1]]}, "issue": "1"}, "alternative-id": ["10.1152/physrev.1961.41.1.52"], "URL": "http://dx.doi.org/10.1152/physrev.1961.41.1.52", "ISSN": ["0031-9333", "1522-1210"], "issn-type": [{"value": "0031-9333", "type": "print"}, {"value": "1522-1210", "type": "electronic"}], "subject": ["Physiology (medical)", "Physiology", "Molecular Biology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T14:57:46Z", "timestamp": 1575212266353}, "reference-count": 0, "publisher": "American Physiological Society", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["American Journal of Physiology-Legacy Content"], "published-print": {"date-parts": [[1959, 8, 1]]}, "abstract": "<jats:p> The addition of dl-carnitine to various types of particulate liver preparations resulted in augmented oxidation of labeled palmitate and stearate. In contrast, carnitine exerted little if any effects upon the degradation of octanoate or laurate. The oxidation of palmityl-1-C<jats:sup>14</jats:sup> CoA by liver particulates was not affected by the presence of carnitine, suggesting that carnitine action is at a stage prior to the formation of this intermediate. Since carnitine addition consistently induced an increase in long chain fatty acid oxidation by slices and by subcellular particulates but did not enhance fatty acid degradation by various soluble systems, it was concluded that an intracellular structure is probably required for carnitine action. A carnitine effect on the long chain fatty acid activating enzyme could not be demonstrated. It was concluded tentatively that the site of carnitine action is independent of direct influence on the known enzymes required for fatty acid oxidation. Palmitic acid oxidation by particulate preparations was inhibited by added serum albumin or calcium, and this inhibition was in large part relieved by the addition of carnitine. </jats:p>", "DOI": "10.1152/ajplegacy.1959.197.2.297", "type": "journal-article", "created": {"date-parts": [[2017, 12, 21]], "date-time": "2017-12-21T16:55:18Z", "timestamp": 1513875318000}, "page": "297-304", "source": "Crossref", "is-referenced-by-count": 145, "title": ["Action of carnitine on long chain fatty acid oxidation by liver"], "prefix": "10.1152", "volume": "197", "author": [{"given": "Irving B.", "family": "Fritz", "sequence": "first", "affiliation": [{"name": "Department of Physiology, University of Michigan, Ann Arbor, Michigan"}]}], "member": "24", "container-title": ["American Journal of Physiology-Legacy Content"], "language": "en", "link": [{"URL": "https://www.physiology.org/doi/pdf/10.1152/ajplegacy.1959.197.2.297", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 8]], "date-time": "2019-09-08T15:43:33Z", "timestamp": 1567957413000}, "score": 20.254938, "issued": {"date-parts": [[1959, 8, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1959, 8, 1]]}, "issue": "2"}, "alternative-id": ["10.1152/ajplegacy.1959.197.2.297"], "URL": "http://dx.doi.org/10.1152/ajplegacy.1959.197.2.297", "ISSN": ["0002-9513"], "issn-type": [{"value": "0002-9513", "type": "print"}], "subject": ["Physiology (medical)"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T18:00:43Z", "timestamp": 1576778443416}, "reference-count": 34, "publisher": "Elsevier BV", "issue": "12", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 12, 1]], "date-time": "2002-12-01T00:00:00Z", "timestamp": 1038700800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2019, 10, 19]], "date-time": "2019-10-19T00:00:00Z", "timestamp": 1571443200000}, "delay-in-days": 6166, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Poultry Science"], "published-print": {"date-parts": [[2002, 12]]}, "DOI": "10.1093/ps/81.12.1898", "type": "journal-article", "created": {"date-parts": [[2014, 2, 7]], "date-time": "2014-02-07T01:00:00Z", "timestamp": 1391734800000}, "page": "1898-1903", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Effect of melatonin supplementation on the ontogeny of immunity in the Large White turkey poult"], "prefix": "10.1016", "volume": "81", "author": [{"given": "CB", "family": "Moore", "sequence": "first", "affiliation": []}, {"given": "TD", "family": "Siopes", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Poultry Science"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0032579119438170?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0032579119438170?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://academic.oup.com/ps/article-pdf/81/12/1898/4414595/poultrysci81-1898.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 11]], "date-time": "2019-12-11T16:04:51Z", "timestamp": 1576080291000}, "score": 20.23024, "issued": {"date-parts": [[2002, 12]]}, "references-count": 34, "journal-issue": {"published-print": {"date-parts": [[2002, 12]]}, "issue": "12"}, "alternative-id": ["S0032579119438170"], "URL": "http://dx.doi.org/10.1093/ps/81.12.1898", "ISSN": ["0032-5791"], "issn-type": [{"value": "0032-5791", "type": "print"}], "subject": ["Animal Science and Zoology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T21:24:36Z", "timestamp": 1574544276957}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 7, 1]], "date-time": "2014-07-01T00:00:00Z", "timestamp": 1404172800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Alzheimer's & Dementia"], "published-print": {"date-parts": [[2014, 7]]}, "DOI": "10.1016/j.jalz.2014.05.626", "type": "journal-article", "created": {"date-parts": [[2014, 9, 6]], "date-time": "2014-09-06T15:03:21Z", "timestamp": 1410015801000}, "page": "P455", "source": "Crossref", "is-referenced-by-count": 1, "title": ["EFFECTS OF OMEGA-3 FATTY ACID SUPPLEMENTATION ON PLASMA FATTY ACIDS, GENDER EFFECTS, AND EFFECTS ON COGNITION IN ALZHEIMER'S PATIENTS: THE OMEGAD STUDY"], "prefix": "10.1016", "volume": "10", "author": [{"given": "Maria", "family": "Eriksdotter", "sequence": "first", "affiliation": []}, {"given": "Farshad", "family": "Falahati", "sequence": "additional", "affiliation": []}, {"given": "Inger", "family": "Vedin", "sequence": "additional", "affiliation": []}, {"given": "Yvonne", "family": "Freund-Levi", "sequence": "additional", "affiliation": []}, {"given": "Erik", "family": "Hjorth", "sequence": "additional", "affiliation": []}, {"given": "Gerd", "family": "Faxen-Irving", "sequence": "additional", "affiliation": []}, {"given": "Lars-Olof", "family": "Wahlund", "sequence": "additional", "affiliation": []}, {"given": "Marianne", "family": "Schultzberg", "sequence": "additional", "affiliation": []}, {"given": "Hans", "family": "Basun", "sequence": "additional", "affiliation": []}, {"given": "Tommy", "family": "Cederholm", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Palmblad", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Alzheimer's & Dementia"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1552526014012734?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1552526014012734?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 30]], "date-time": "2018-09-30T01:57:49Z", "timestamp": 1538272669000}, "score": 19.887634, "issued": {"date-parts": [[2014, 7]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 7]]}, "issue": "4"}, "alternative-id": ["S1552526014012734"], "URL": "http://dx.doi.org/10.1016/j.jalz.2014.05.626", "ISSN": ["1552-5260"], "issn-type": [{"value": "1552-5260", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:10:57Z", "timestamp": 1574399457388}, "reference-count": 0, "publisher": "Canadian Science Publishing", "issue": "3", "license": [{"URL": "http://www.nrcresearchpress.com/page/about/CorporateTextAndDataMining", "start": {"date-parts": [[1970, 3, 1]], "date-time": "1970-03-01T00:00:00Z", "timestamp": 5097600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Can. J. Biochem."], "published-print": {"date-parts": [[1970, 3]]}, "DOI": "10.1139/o70-050", "type": "journal-article", "created": {"date-parts": [[2009, 12, 17]], "date-time": "2009-12-17T22:11:52Z", "timestamp": 1261087912000}, "page": "288-294", "source": "Crossref", "is-referenced-by-count": 48, "title": ["Carnitine palmitoyltransferase activity and fatty acid oxidation by livers from fetal and neonatal rats"], "prefix": "10.1139", "volume": "48", "author": [{"given": "John", "family": "Augenfeld", "sequence": "first", "affiliation": []}, {"given": "Irving B.", "family": "Fritz", "sequence": "additional", "affiliation": []}], "member": "155", "container-title": ["Canadian Journal of Biochemistry"], "language": "en", "link": [{"URL": "http://www.nrcresearchpress.com/doi/pdf/10.1139/o70-050", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 15]], "date-time": "2017-10-15T21:27:55Z", "timestamp": 1508102875000}, "score": 19.528904, "issued": {"date-parts": [[1970, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1970, 3]]}, "issue": "3"}, "alternative-id": ["10.1139/o70-050"], "URL": "http://dx.doi.org/10.1139/o70-050", "ISSN": ["0008-4018"], "issn-type": [{"value": "0008-4018", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T18:02:11Z", "timestamp": 1575136931525}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Am. Chem. Soc."], "published-print": {"date-parts": [[1936, 2]]}, "DOI": "10.1021/ja01293a028", "type": "journal-article", "created": {"date-parts": [[2005, 3, 19]], "date-time": "2005-03-19T15:38:24Z", "timestamp": 1111246704000}, "page": "284-287", "source": "Crossref", "is-referenced-by-count": 109, "title": ["Composition of Fatty Acid Films on Water Containing Calcium or Barium Salts"], "prefix": "10.1021", "volume": "58", "author": [{"given": "Irving", "family": "Langmuir", "sequence": "first", "affiliation": []}, {"given": "Vincent J.", "family": "Schaefer", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Journal of the American Chemical Society"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/ja01293a028", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 29]], "date-time": "2019-09-29T13:06:04Z", "timestamp": 1569762364000}, "score": 19.528904, "issued": {"date-parts": [[1936, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1936, 2]]}, "issue": "2"}, "alternative-id": ["10.1021/ja01293a028"], "URL": "http://dx.doi.org/10.1021/ja01293a028", "ISSN": ["0002-7863", "1520-5126"], "issn-type": [{"value": "0002-7863", "type": "print"}, {"value": "1520-5126", "type": "electronic"}], "subject": ["Colloid and Surface Chemistry", "Biochemistry", "General Chemistry", "Catalysis"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T09:30:16Z", "timestamp": 1575451816860}, "edition-number": "1", "reference-count": 0, "publisher": "Routledge", "isbn-type": [{"value": "9780203774557", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.4324/9780203774557", "type": "book", "created": {"date-parts": [[2014, 3, 14]], "date-time": "2014-03-14T09:07:58Z", "timestamp": 1394788078000}, "source": "Crossref", "is-referenced-by-count": 1, "title": ["Psychodiagnosis in Schizophrenia"], "prefix": "10.4324", "author": [{"given": "Irving B.", "family": "Weiner", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2013, 6, 17]]}, "deposited": {"date-parts": [[2018, 9, 4]], "date-time": "2018-09-04T16:46:54Z", "timestamp": 1536079614000}, "score": 19.502583, "issued": {"date-parts": [[2013, 6, 17]]}, "ISBN": ["9780203774557"], "references-count": 0, "URL": "http://dx.doi.org/10.4324/9780203774557"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:24:08Z", "timestamp": 1574151848000}, "reference-count": 30, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1988, 2, 1]], "date-time": "1988-02-01T00:00:00Z", "timestamp": 570672000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism"], "published-print": {"date-parts": [[1988, 2]]}, "DOI": "10.1016/0005-2760(88)90176-2", "type": "journal-article", "created": {"date-parts": [[2003, 2, 11]], "date-time": "2003-02-11T11:17:51Z", "timestamp": 1044962271000}, "page": "188-198", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Fat pad triacylglycerol fatty acid loss and oxidation as indices of total body triacylglycerol fatty acid mobilization and oxidation in starving mice"], "prefix": "10.1016", "volume": "958", "author": [{"given": "Irving", "family": "Lyon", "sequence": "first", "affiliation": []}, {"given": "Murad", "family": "Ookhtens", "sequence": "additional", "affiliation": []}, {"given": "Dominic", "family": "Montisano", "sequence": "additional", "affiliation": []}, {"given": "Nome", "family": "Baker", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0005276088901762?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0005276088901762?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 29]], "date-time": "2019-03-29T09:50:36Z", "timestamp": 1553853036000}, "score": 19.451958, "issued": {"date-parts": [[1988, 2]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[1988, 2]]}, "issue": "2"}, "alternative-id": ["0005276088901762"], "URL": "http://dx.doi.org/10.1016/0005-2760(88)90176-2", "ISSN": ["0005-2760"], "issn-type": [{"value": "0005-2760", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T14:56:20Z", "timestamp": 1574348180540}, "reference-count": 5, "publisher": "Emerald", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["BLL Review"], "published-print": {"date-parts": [[1976, 1]]}, "DOI": "10.1108/eb008462", "type": "journal-article", "created": {"date-parts": [[2008, 2, 2]], "date-time": "2008-02-02T13:23:05Z", "timestamp": 1201958585000}, "page": "3-6", "source": "Crossref", "is-referenced-by-count": 2, "title": ["THE GROWTH OF THE LITERATURE AND ITS IMPLICATIONS FOR LIBRARY STORAGE 1. MONOGRAPHS"], "prefix": "10.1108", "volume": "4", "author": [{"given": "CB", "family": "Wootton", "sequence": "first", "affiliation": []}], "member": "140", "reference": [{"key": "p_1", "author": "Design", "year": "1974", "volume-title": "Working Paper No 7: Size and growth of monograph literature"}, {"key": "p_2", "author": "Barr DR.", "year": "1972", "volume-title": "Trends in book production and prices"}, {"key": "p_4", "author": "Balmforth CK.", "first-page": "33", "year": "1973", "volume-title": "Jeffreys, A (ed) The art of the librarian"}, {"key": "p_5", "DOI": "10.1126/science.183.4122.282", "doi-asserted-by": "publisher"}, {"key": "p_6", "author": "Publishers Association", "year": "1975", "volume-title": "Technical and Scientific Group. Ongoing study"}], "container-title": ["BLL Review"], "language": "en", "deposited": {"date-parts": [[2019, 9, 3]], "date-time": "2019-09-03T19:58:44Z", "timestamp": 1567540724000}, "score": 19.418789, "issued": {"date-parts": [[1976, 1]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[1976, 1]]}, "issue": "1"}, "alternative-id": ["10.1108/eb008462"], "URL": "http://dx.doi.org/10.1108/eb008462", "relation": {"cites": []}, "ISSN": ["0305-6503"], "issn-type": [{"value": "0305-6503", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T14:56:20Z", "timestamp": 1574348180563}, "reference-count": 6, "publisher": "Emerald", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["BLL Review"], "published-print": {"date-parts": [[1976, 2]]}, "DOI": "10.1108/eb008467", "type": "journal-article", "created": {"date-parts": [[2008, 2, 2]], "date-time": "2008-02-02T13:23:07Z", "timestamp": 1201958587000}, "page": "41-46", "source": "Crossref", "is-referenced-by-count": 0, "title": ["THE GROWTH OF THE LITERATURE AND ITS IMPLICATIONS FOR LIBRARY STORAGE 2. SERIALS"], "prefix": "10.1108", "volume": "4", "author": [{"given": "CB", "family": "Wootton", "sequence": "first", "affiliation": []}], "member": "140", "reference": [{"key": "p_1", "DOI": "10.1108/eb008462", "doi-asserted-by": "publisher"}, {"key": "p_2", "author": "Barr DR.", "year": "1972", "volume-title": "Trends in book production and prices"}, {"issue": "11", "key": "p_3", "first-page": "9", "volume": "17", "author": "Bryan H", "year": "1968", "journal-title": "Australian Library Journal"}, {"key": "p_4", "DOI": "10.1108/eb026424", "doi-asserted-by": "publisher"}, {"key": "p_5", "DOI": "10.1108/eb026544", "doi-asserted-by": "publisher"}, {"key": "p_7", "author": "Department of Education and Science.", "volume": "6", "volume-title": "Universities (annual) HMSO."}], "container-title": ["BLL Review"], "language": "en", "deposited": {"date-parts": [[2019, 9, 3]], "date-time": "2019-09-03T19:58:31Z", "timestamp": 1567540711000}, "score": 19.418789, "issued": {"date-parts": [[1976, 2]]}, "references-count": 6, "journal-issue": {"published-print": {"date-parts": [[1976, 2]]}, "issue": "2"}, "alternative-id": ["10.1108/eb008467"], "URL": "http://dx.doi.org/10.1108/eb008467", "relation": {"cites": []}, "ISSN": ["0305-6503"], "issn-type": [{"value": "0305-6503", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T16:04:04Z", "timestamp": 1576857844214}, "reference-count": 39, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 598, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Intern Med"], "published-print": {"date-parts": [[2014, 4]]}, "DOI": "10.1111/joim.12166", "type": "journal-article", "created": {"date-parts": [[2013, 11, 25]], "date-time": "2013-11-25T10:25:38Z", "timestamp": 1385375138000}, "page": "428-436", "source": "Crossref", "is-referenced-by-count": 63, "title": ["Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study"], "prefix": "10.1111", "volume": "275", "author": [{"given": "Y.", "family": "Freund Levi", "sequence": "first", "affiliation": [{"name": "Department of Neurobiology, Caring Sciences and Society; Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden"}]}, {"given": "I.", "family": "Vedin", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden"}]}, {"given": "T.", "family": "Cederholm", "sequence": "additional", "affiliation": [{"name": "Department of Public Health and Caring Sciences; Uppsala University Hospital; Uppsala Sweden"}, {"name": "Division of Clinical Nutrition and Metabolism; Uppsala University Hospital; Uppsala Sweden"}]}, {"given": "H.", "family": "Basun", "sequence": "additional", "affiliation": [{"name": "Department of Public Health and Caring Sciences; Uppsala University Hospital; Uppsala Sweden"}, {"name": "Division of Geriatrics; Uppsala University Hospital; Uppsala Sweden"}]}, {"given": "G.", "family": "Fax\u00e9n Irving", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Caring Sciences and Society; Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden"}]}, {"given": "M.", "family": "Eriksdotter", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Caring Sciences and Society; Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden"}]}, {"given": "E.", "family": "Hjorth", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Caring Sciences and Society; Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden"}]}, {"given": "M.", "family": "Schultzberg", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Caring Sciences and Society; Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden"}]}, {"given": "B.", "family": "Vessby", "sequence": "additional", "affiliation": [{"name": "Department of Public Health and Caring Sciences; Uppsala University Hospital; Uppsala Sweden"}, {"name": "Division of Geriatrics; Uppsala University Hospital; Uppsala Sweden"}]}, {"given": "L.-O.", "family": "Wahlund", "sequence": "additional", "affiliation": [{"name": "Department of Neurobiology, Caring Sciences and Society; Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden"}]}, {"suffix": "Jr", "given": "N.", "family": "Salem", "sequence": "additional", "affiliation": [{"name": "National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health; Rockville MD USA"}]}, {"given": "J.", "family": "Palmblad", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; Karolinska Institutet; Karolinska University Hospital Huddinge; Stockholm Sweden"}]}], "member": "311", "published-online": {"date-parts": [[2014, 1, 11]]}, "reference": [{"key": "10.1111/joim.12166-BIB0001|joim12166-cit-0001", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1093/ajcn/65.2.465", "article-title": "Retinal and brain accretion of long-chain polyunsaturated fatty acids in developing felines: the effects of corn oil-based maternal diets", "volume": "65", "author": "Pawlosky", "year": "1997", "journal-title": "Am J Clin Nutr"}, {"key": "10.1111/joim.12166-BIB0002|joim12166-cit-0002", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1093/jn/135.3.549", "article-title": "Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats", "volume": "135", "author": "Hashimoto", "year": "2005", "journal-title": "J Nutr"}, {"key": "10.1111/joim.12166-BIB0003|joim12166-cit-0003", "doi-asserted-by": "crossref", "first-page": "1200", "DOI": "10.1111/j.1471-4159.1990.tb03125.x", "article-title": "Effects of dietary n-3 fatty acids on the phospholipid molecular species of monkey brain", "volume": "55", "author": "Lin", "year": "1990", "journal-title": "J Neurochem"}, {"key": "10.1111/joim.12166-BIB0004|joim12166-cit-0004", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1203/01.pdr.0000182188.31596.5a", "article-title": "Can prenatal N-3 fatty acid deficiency be completely reversed after birth? Effects on retinal and brain biochemistry and visual function in rhesus monkeys", "volume": "58", "author": "Anderson", "year": "2005", "journal-title": "Pediatr Res"}, {"key": "10.1111/joim.12166-BIB0005|joim12166-cit-0005", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1007/BF02536067", "article-title": "Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease", "volume": "26", "author": "S\u00f6derberg", "year": "1991", "journal-title": "Lipids"}, {"key": "10.1111/joim.12166-BIB0006|joim12166-cit-0006", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.3233/JAD-2010-1242", "article-title": "Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex", "volume": "19", "author": "Mart\u00edn", "year": "2010", "journal-title": "J Alzheimers Dis"}, {"key": "10.1111/joim.12166-BIB0007|joim12166-cit-0007", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1079/BJN2002804", "article-title": "Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study", "volume": "89", "author": "Tully", "year": "2003", "journal-title": "Br J Nutr"}, {"key": "10.1111/joim.12166-BIB0008|joim12166-cit-0008", "doi-asserted-by": "crossref", "first-page": "864", "DOI": "10.3945/jn.109.113233", "article-title": "DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders", "volume": "140", "author": "McNamara", "year": "2010", "journal-title": "J Nutr"}, {"key": "10.1111/joim.12166-BIB0009|joim12166-cit-0009", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1097/MCO.0b013e328335c40b", "article-title": "Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?", "volume": "13", "author": "Cederholm", "year": "2010", "journal-title": "Curr Opin Clin Nutr Metab Care"}, {"key": "10.1111/joim.12166-BIB0010|joim12166-cit-0010", "doi-asserted-by": "crossref", "first-page": "1545", "DOI": "10.1001/archneur.63.11.1545", "article-title": "Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study", "volume": "63", "author": "Schaefer", "year": "2006", "journal-title": "Arch Neurol"}, {"key": "10.1111/joim.12166-BIB0011|joim12166-cit-0011", "doi-asserted-by": "crossref", "first-page": "1402", "DOI": "10.1001/archneur.63.10.1402", "article-title": "Omega-3 fatty acid supplementation delays the cognitive decline in patients with very mild Alzheimer's disease - a 1-year randomized placebo-controlled study of 174 patients", "volume": "63", "author": "Freund Levi", "year": "2006", "journal-title": "Arch Neurol"}, {"key": "10.1111/joim.12166-BIB0012|joim12166-cit-0012", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1016/j.jalz.2010.01.013", "article-title": "Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline", "volume": "6", "author": "Yurko-Mauro", "year": "2010", "journal-title": "Alzheimers Dement"}, {"key": "10.1111/joim.12166-BIB0013|joim12166-cit-0013", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.4088/JCP.10r06710", "article-title": "Omega-3 for bipolar disorder: metaanalyses of use in mania and bipolar depression", "volume": "73", "author": "Sarris", "year": "2012", "journal-title": "J Clin Psychiatry"}, {"key": "10.1111/joim.12166-BIB0014|joim12166-cit-0014", "doi-asserted-by": "crossref", "first-page": "1103", "DOI": "10.1093/ajcn/85.4.1103", "article-title": "Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study", "volume": "85", "author": "Beydoun", "year": "2007", "journal-title": "Am J Clin Nutr"}, {"key": "10.1111/joim.12166-BIB0015|joim12166-cit-0015", "doi-asserted-by": "crossref", "first-page": "803", "DOI": "10.1093/ajcn/77.4.803", "article-title": "Cognitive decline and fatty acid composition of erythrocyte membranes. The EVA Study", "volume": "77", "author": "Heude", "year": "2003", "journal-title": "Am J Clin Nutr"}, {"key": "10.1111/joim.12166-BIB0016|joim12166-cit-0016", "doi-asserted-by": "crossref", "first-page": "1903", "DOI": "10.1001/jama.2010.1510", "article-title": "Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease. A randomized trial", "volume": "304", "author": "Quinn", "year": "2010", "journal-title": "JAMA"}, {"key": "10.1111/joim.12166-BIB0017|joim12166-cit-0017", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1159/000218081", "article-title": "Effects of omega-3 fatty acids on inflammatory markers in CSF and plasma in Alzheimer's disease. The OmegAD study", "volume": "27", "author": "Freund Levi", "year": "2009", "journal-title": "Dement Geriatr Cogn Disord"}, {"key": "10.1111/joim.12166-BIB0018|joim12166-cit-0018", "doi-asserted-by": "crossref", "first-page": "911", "DOI": "10.1139/o59-099", "article-title": "A rapid method of total lipid extraction and purification", "volume": "37", "author": "Bligh", "year": "1959", "journal-title": "Can J Biochem Physiol"}, {"key": "10.1111/joim.12166-BIB0019|joim12166-cit-0019", "first-page": "600", "article-title": "Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron-fluoride methanol", "volume": "5", "author": "Morrison", "year": "1964", "journal-title": "J Lipid Res"}, {"key": "10.1111/joim.12166-BIB0020|joim12166-cit-0020", "doi-asserted-by": "crossref", "first-page": "1265", "DOI": "10.1023/A:1014227231130", "article-title": "Quantification of free fatty acids in human cerebrospinal fluid", "volume": "26", "author": "Pilitsis", "year": "2001", "journal-title": "Neurochem Res"}, {"key": "10.1111/joim.12166-BIB0021|joim12166-cit-0021", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/j.plefa.2008.09.010", "article-title": "Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease", "volume": "79", "author": "Rapoport", "year": "2008", "journal-title": "Prostaglandins Leukot Essent Fatty Acids"}, {"key": "10.1111/joim.12166-BIB0022|joim12166-cit-0022", "first-page": "1026", "article-title": "DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects", "volume": "88", "author": "Perez", "year": "2010", "journal-title": "J Neurosci Res"}, {"key": "10.1111/joim.12166-BIB0023|joim12166-cit-0023", "doi-asserted-by": "crossref", "first-page": "482", "DOI": "10.1016/j.nbd.2008.12.002", "article-title": "DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice", "volume": "33", "author": "Hooijmans", "year": "2009", "journal-title": "Neurobiol Dis"}, {"key": "10.1111/joim.12166-BIB0024|joim12166-cit-0024", "doi-asserted-by": "crossref", "first-page": "4385", "DOI": "10.1523/JNEUROSCI.0055-07.2007", "article-title": "Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels", "volume": "27", "author": "Green", "year": "2007", "journal-title": "J Neurosci"}, {"key": "10.1111/joim.12166-BIB0025|joim12166-cit-0025", "doi-asserted-by": "crossref", "first-page": "633", "DOI": "10.1016/j.neuron.2004.08.013", "article-title": "Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model", "volume": "43", "author": "Calon", "year": "2004", "journal-title": "Neuron"}, {"key": "10.1111/joim.12166-BIB0026|joim12166-cit-0026", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1016/j.nbd.2006.04.013", "article-title": "Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice", "volume": "23", "author": "Oksman", "year": "2006", "journal-title": "Neurobiol Dis"}, {"key": "10.1111/joim.12166-BIB0027|joim12166-cit-0027", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/j.bbalip.2005.11.011", "article-title": "Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions", "volume": "1738", "author": "Hashimoto", "year": "2005", "journal-title": "Biochim Biophys Acta"}, {"key": "10.1111/joim.12166-BIB0028|joim12166-cit-0028", "doi-asserted-by": "crossref", "first-page": "3032", "DOI": "10.1523/JNEUROSCI.4225-04.2005", "article-title": "A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model", "volume": "25", "author": "Lim", "year": "2005", "journal-title": "J Neurosci"}, {"key": "10.1111/joim.12166-BIB0029|joim12166-cit-0029", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1038/nrneurol.2010.4", "article-title": "Cerebrospinal fluid and plasma biomarkers in Alzheimer disease", "volume": "6", "author": "Blennow", "year": "2010", "journal-title": "Nat Rev Neurol"}, {"key": "10.1111/joim.12166-BIB0030|joim12166-cit-0030", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.jalz.2009.10.003", "article-title": "Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial", "volume": "6", "author": "Scheltens", "year": "2010", "journal-title": "Alzheimers Dement"}, {"key": "10.1111/joim.12166-BIB0031|joim12166-cit-0031", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1038/nri2294", "article-title": "Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators", "volume": "8", "author": "Serhan", "year": "2008", "journal-title": "Nat Rev Immunol"}, {"key": "10.1111/joim.12166-BIB0032|joim12166-cit-0032", "doi-asserted-by": "crossref", "first-page": "476", "DOI": "10.1016/j.neuint.2009.04.018", "article-title": "Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study", "volume": "55", "author": "Ouellet", "year": "2009", "journal-title": "Neurochem Int"}, {"key": "10.1111/joim.12166-BIB0033|joim12166-cit-0033", "doi-asserted-by": "crossref", "first-page": "1259", "DOI": "10.1194/jlr.M800530-JLR200", "article-title": "Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography", "volume": "50", "author": "Umhau", "year": "2009", "journal-title": "J Lipid Res"}, {"key": "10.1111/joim.12166-BIB0034|joim12166-cit-0034", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/j.brainresrev.2010.04.006", "article-title": "The formation of cerebrospinal fluid: nearly a hundred years of interpretations and misinterpretations", "volume": "64", "author": "Oreskovic", "year": "2010", "journal-title": "Brain Res Rev"}, {"key": "10.1111/joim.12166-BIB0035|joim12166-cit-0035", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1007/s00281-009-0177-0", "article-title": "The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction", "volume": "31", "author": "Engelhardt", "year": "2009", "journal-title": "Semin Immunopathol"}, {"key": "10.1111/joim.12166-BIB0036|joim12166-cit-0036", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/j.plefa.2008.09.003", "article-title": "Regulation of brain polyunsaturated fatty acid uptake and turnover", "volume": "79", "author": "Chen", "year": "2008", "journal-title": "Prostaglandins Leukot Essent Fatty Acids"}, {"key": "10.1111/joim.12166-BIB0037|joim12166-cit-0037", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1111/j.1471-4159.2010.07116.x", "article-title": "Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study", "volume": "116", "author": "Chen", "year": "2011", "journal-title": "J Neurochem"}, {"key": "10.1111/joim.12166-BIB0038|joim12166-cit-0038", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/j.plefa.2009.01.005", "article-title": "Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study", "volume": "80", "author": "Chen", "year": "2009", "journal-title": "Prostaglandins Leukot Essent Fatty Acids"}, {"key": "10.1111/joim.12166-BIB0039|joim12166-cit-0039", "doi-asserted-by": "crossref", "first-page": "1482.e17", "DOI": "10.1016/j.neurobiolaging.2011.12.014", "article-title": "Effects of omega-3 fatty acids on cognitive performance: a meta-analysis", "volume": "33", "author": "Mazereeuw", "year": "2012", "journal-title": "Neurobiol Ageing"}], "container-title": ["Journal of Internal Medicine"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjoim.12166", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 4]], "date-time": "2019-08-04T01:35:27Z", "timestamp": 1564882527000}, "score": 19.37183, "issued": {"date-parts": [[2014, 1, 11]]}, "references-count": 39, "journal-issue": {"published-print": {"date-parts": [[2014, 4]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1111/joim.12166", "relation": {"cites": []}, "ISSN": ["0954-6820"], "issn-type": [{"value": "0954-6820", "type": "print"}], "subject": ["Internal Medicine"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}